{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04670",
    "Peptide Name": "Lf-KR (Synthetic AMPs, Hybrid peptide LfcinB6 + KR-12-a4, XXA, UCLL1c)",
    "Source": "Hybrid peptide, designed",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "RRWQWRPKRIVKLIKKWLR",
    "Sequence Length": 19,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 10,
    "Boman Index": 3.76,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "42%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (63.16%) toKR-12-a4R: 26%, K: 21%, W: 16%, I=L: 11%. It is a hybrid of KR-12-a4 and LfcinB6.Activity: active against Gram+ S. aureus KCTC 1621 or MRSA (MIC 4-8 uM), S. epidermidis KCTC 1917 (MIC 8 uM), B. subtilis KCTC 3068 (MIC 4 uM), vancomycin-resistant E. faecium (MIC 8 uM) anti-VRE, Gram- E. coli KCTC 1682 (MIC 8 uM), P. aeruginosa KCTC 1637 or multidrug-resistant strains (MIC 8 uM), and S. typhimurium KCTC 1926 (MIC 4 uM).Structure: helical in 50% TFE, 30 mM SDS, and EYPC/EYPG lipid vesicles.",
    "Author": "Ajish C, Yang S, Kumar SD, Kim EY, Min HJ, Lee CW, Shin SH, Shin SY. 2022",
    "Reference": "Sci Rep. 2022 Mar 14;12(1):4365. doi: 10.1038/s41598-022-08247-4.PubMed",
    "Title": "A novel hybrid peptide composed of LfcinB6 and KR-12-a4 with enhanced antimicrobial, anti-inflammatory and anti-biofilm activities."
  },
  "3D Structure": []
}